Information Event | How diagnostics SMEs benefit from Codex4SMEs services
February 8 @ 10:00 – 11:30
Online seminar. Wednesday February 8th, 2023, 10:00 – 11:30 (CET, Amsterdam, Berlin, Paris)
Registration: Zoom link (participation is free of charge)
The Interreg North-West Europe Codex4SMEs support programme offers a wide range of services to small and medium-sized enterprises (SMEs) in the life sciences and medical technology sectors working on the development of diagnostics.
The information event provides attendees with details about the application process for Codex4SMEs services, eligibility criteria for applicants, and the scope of services. Experts from EATRIS and IBBL will present details of the following services:
- Translational assessment provided by EATRIS
- Modular biomarker validation services provided by IBBL
- Tailored consultancy services on specific biomarker topics provided by IBBL
- Interactive online seminars on biomarker validation topics provided by IBBL
EATRIS Translational Assessment supports SMEs in assessing and optimising the translational feasibility and potential of their projects. By providing feedback on issues such as medical need, market and pipeline overview, regulatory pathway, intellectual property and translational tools, early-stage companies can optimise their plans according to the realities of the development pipeline.
The Translational Biomarker Group at the Integrated Biobank of Luxembourg (IBBL) supports SMEs by providing a biomarker pre-clinical validation service. Biomarker technical validation is an essential tool to increase the chances for a successful exploitation of newly discovered and repurposable biomarkers into powerful diagnostic tools, predictors for proper treatments, or Companion Diagnostics (Cdx).
|10:00 – 10:10||Welcome and introduction of Codex4SMEs projectSpeaker: Sara Zullino, EATRIS|
|10:10 – 10:25||“EATRIS, the European Research Infrastructure for Translational Medicine”Speaker: Sara Zullino, Scientific & SME Outreach Manager, EATRIS|
|10:25 – 10:40||“Intellectual Property: Improving chances for translation”Speaker: Tim Moser, Business Development Manager, The Netherlands Cancer Institute (NKI)|
|10:40 – 10:55||“From the idea to the market: Regulatory Strategy is a Key Factor to Success”Speaker: Miguel Angel Souto Mora, Director of the Business Development and Innovation Area, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL)|
|10:55 – 11:10||“Health Technology Assessment: the importance of multidimensional analysis at different stages of development of health technologies”Speaker: Umberto Restelli, Università Carlo Cattaneo (LIUC)|
|11:10 – 11:15||“Biomarker validation: a valuable Codex4SMEs tool”Speaker: Monica Marchese, Translational Biomarker Group Leader, Integrated BioBank of Luxembourg|
|11:15 – 11:30||Q&A SessionModerator: Sara Zullino, EATRIS|
SMEs eligible to apply for Codex4SMEs service coming from the life sciences or medical technology sector with headquarters located in the North-West Europe countries. The costs for services are covered by the EU-funded Interreg NWE Codex4SMEs project.
The Webinar will be recorded until Q&A Session
Discover more about BioRegio STERN Management GmbH:
BioRegio STERN Management GmbH is the lead partner in the Interreg NWE project Codex4SMEs. Based in southwest Germany, BioRegio STERN Management GmbH acts as a business development agency for the regional biotech and life science sector. The primary goal is to anchor the BioRegion STERN and their business throughout Germany and internationally on a high level. An important strategy for the development of the regional cluster is to build on existing strengths. The regions Stuttgart and Tübingen are characterised by a prominent network of biotechnology and medical technology SMEs as well as universities & research institutes and including service provider companies.